首页 > 最新文献

Journal of Current Ophthalmology最新文献

英文 中文
A Case of Infantile Cataract and Neonatal Hypoglycemia. 一例婴儿白内障和新生儿低血糖症病例
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_353_22
Rym Maamouri, Molka Ferchichi, Amel Ben Chehida, Monia Cheour

Purpose: To describe a case of lamellar cataract in a child with a history of neonatal hypoglycemia and illustrate the importance of meticulous history-taking in children with cataracts, especially before planning surgery.

Methods: A single case report.

Results: A 7-year-old girl with a history of neonatal hypoglycemia and ketoacidosis with high suspicion of a primary defect in ketone body utilization who presented with bilateral progressive blurred vision. Her best-corrected visual acuity (BCVA) was 20/200 in her right eye (OD) and 20/400 in her left eye (OS). Slit-lamp examination showed the presence of bilateral dense lamellar cataract. Fundus examination was unremarkable in both eyes (OU). She underwent cataract surgery with intraocular lens implantation under general anesthesia without prolonged fasting. Final BCVA was 20/82 in OD and 20/63 in OS.

Conclusion: Our aim through this case is to emphasize the importance to screen for episodes of hypoglycemic attacks in children with infantile cataracts.

目的:描述一例有新生儿低血糖病史的片状白内障患儿,并说明对白内障患儿进行细致病史采集的重要性,尤其是在计划手术之前:方法:单个病例报告:一名 7 岁女孩,曾有新生儿低血糖和酮症酸中毒病史,高度怀疑酮体利用存在原发性缺陷,出现双侧进行性视力模糊。她的右眼最佳矫正视力(BCVA)为 20/200,左眼为 20/400。裂隙灯检查显示她患有双侧致密片状白内障。双眼眼底检查无异常。在没有长时间禁食的情况下,她在全身麻醉下接受了白内障手术和人工晶体植入术。最终双眼视力分别为 20/82(OD)和 20/63(OS):我们希望通过这个病例强调筛查婴幼儿白内障患儿低血糖发作的重要性。
{"title":"A Case of Infantile Cataract and Neonatal Hypoglycemia.","authors":"Rym Maamouri, Molka Ferchichi, Amel Ben Chehida, Monia Cheour","doi":"10.4103/joco.joco_353_22","DOIUrl":"https://doi.org/10.4103/joco.joco_353_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a case of lamellar cataract in a child with a history of neonatal hypoglycemia and illustrate the importance of meticulous history-taking in children with cataracts, especially before planning surgery.</p><p><strong>Methods: </strong>A single case report.</p><p><strong>Results: </strong>A 7-year-old girl with a history of neonatal hypoglycemia and ketoacidosis with high suspicion of a primary defect in ketone body utilization who presented with bilateral progressive blurred vision. Her best-corrected visual acuity (BCVA) was 20/200 in her right eye (OD) and 20/400 in her left eye (OS). Slit-lamp examination showed the presence of bilateral dense lamellar cataract. Fundus examination was unremarkable in both eyes (OU). She underwent cataract surgery with intraocular lens implantation under general anesthesia without prolonged fasting. Final BCVA was 20/82 in OD and 20/63 in OS.</p><p><strong>Conclusion: </strong>Our aim through this case is to emphasize the importance to screen for episodes of hypoglycemic attacks in children with infantile cataracts.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Anterior Chamber Diaphragm": A Temporary Device to Make Corneal Endothelial Cell Therapy Safe! "前房隔膜":使角膜内皮细胞疗法安全的临时装置!
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_134_23
Mahsa Yousefpour-Marzbali, Hassan Asadigandomani, Maryam Soleimanifar, Amirhossein Bahmanpour, Seyed-Mehrdad Mohammadi, Seyed-Farzad Mohammadi
{"title":"\"Anterior Chamber Diaphragm\": A Temporary Device to Make Corneal Endothelial Cell Therapy Safe!","authors":"Mahsa Yousefpour-Marzbali, Hassan Asadigandomani, Maryam Soleimanifar, Amirhossein Bahmanpour, Seyed-Mehrdad Mohammadi, Seyed-Farzad Mohammadi","doi":"10.4103/joco.joco_134_23","DOIUrl":"https://doi.org/10.4103/joco.joco_134_23","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Histopathologic Findings and Safety of Intravitreal Ketamine Administration on Vitreoretinal Tissue in Rat Model: A Pilot Study. 评估大鼠模型玻璃体内氯胺酮给药对玻璃体视网膜组织的组织病理学结果和安全性:一项试验性研究。
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_230_23
Mehdi Sanatkar, Zohreh Nozarian, Parisa Abdi, Fatemeh Bazvand

Purpose: To evaluate the safety and histological findings of intravitreal injection of ketamine in rats.

Methods: Each rat received a total volume of 0.1 ml of ketamine 0.01 mol/L (5 rats as ketamine group) or a total of 0.1 ml of normal saline 0.9% (5 rats as control group) under general anesthesia in a sterile condition. A histology assessment was performed 1 month after the intravitreal injection.

Results: Lens opacity, necrosis, and atrophy of retinal layers and optic disc were not seen in five specimens in the ketamine group and five in the normal saline group. There was no inflammation in the vitreous, retinal layers, choroid, optic disc, and optic nerve in both groups.

Conclusion: Intravitreal injection of ketamine in a special dose has no obvious adverse effect on diverse intraocular tissue.

目的:评估大鼠玻璃体内注射氯胺酮的安全性和组织学结果:方法:在无菌条件下全身麻醉,每只大鼠接受总量为0.1 ml的0.01 mol/L氯胺酮(5只大鼠为氯胺酮组)或总量为0.1 ml的0.9%生理盐水(5只大鼠为对照组)。玻璃体内注射 1 个月后进行组织学评估:结果:氯胺酮组和生理盐水组的 5 份标本均未出现晶状体混浊、视网膜层和视盘坏死和萎缩。两组样本的玻璃体、视网膜层、脉络膜、视盘和视神经均未出现炎症:结论:特殊剂量的氯胺酮玻璃体内注射对不同的眼内组织没有明显的不良影响。
{"title":"Evaluation of Histopathologic Findings and Safety of Intravitreal Ketamine Administration on Vitreoretinal Tissue in Rat Model: A Pilot Study.","authors":"Mehdi Sanatkar, Zohreh Nozarian, Parisa Abdi, Fatemeh Bazvand","doi":"10.4103/joco.joco_230_23","DOIUrl":"https://doi.org/10.4103/joco.joco_230_23","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and histological findings of intravitreal injection of ketamine in rats.</p><p><strong>Methods: </strong>Each rat received a total volume of 0.1 ml of ketamine 0.01 mol/L (5 rats as ketamine group) or a total of 0.1 ml of normal saline 0.9% (5 rats as control group) under general anesthesia in a sterile condition. A histology assessment was performed 1 month after the intravitreal injection.</p><p><strong>Results: </strong>Lens opacity, necrosis, and atrophy of retinal layers and optic disc were not seen in five specimens in the ketamine group and five in the normal saline group. There was no inflammation in the vitreous, retinal layers, choroid, optic disc, and optic nerve in both groups.</p><p><strong>Conclusion: </strong>Intravitreal injection of ketamine in a special dose has no obvious adverse effect on diverse intraocular tissue.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Abelson Helper Integration Site 1, Nebulin, and Paired Box 3 Genes in the Development of Nonsyndromic Strabismus in a Series of Iranian Families: Sequence Analysis and Systematic Review of the Genetics of Nonsyndromic Strabismus. 阿贝尔森辅助整合位点 1、Nebulin 和配对框 3 基因在一系列伊朗家族非综合征斜视发病中的作用:非综合征斜视遗传学的序列分析和系统回顾。
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_53_22
Maliheh Rahpeyma, Aliakbar Sabermoghaddam, Mohammad Yaser Kiarudi, Amirsaeed Sabeti Aghabozorgi, Alireza Pasdar

Purpose: To look for causative genetic mutations in a series of Iranian families with strabismus. In addition, we systematically reviewed all the published articles regarding the role of genetic variations in primary and nonsyndromic comitant strabismus.

Methods: Four families with a history of multiple cases of primary and nonsyndromic comitant strabismus were enrolled in this study. Polymerase chain reaction and Sanger sequencing of exons 23, 11, and 3 of the Abelson helper integration site 1 (AHI1), nebulin (NEB), and paired box 3 (PAX3) genes were performed, respectively. One offspring of a consanguineous marriage underwent whole-exome sequencing (WES) to look for possible causative variants. To conduct a systematic review, we thoroughly searched PubMed, Scopus, and ISI Web of Knowledge extracting relevant publications, released by April 2021.

Results: We examined four Iranian strabismus pedigrees with multiple affected offspring in different generations. Among these 17 participants, 10 family members had strabismus and 7 were healthy. Sanger sequencing did not reveal a causative mutation. Therefore, to further investigate, one affected offspring was chosen for WES. The WES study demonstrated two possible variants in MYO5B and DHODH genes. These genetic variants showed high allele frequency in our population and are thought to be polymorphisms in our series of Iranian families.

Conclusions: We demonstrated that mutations in AHI1, NEB, and PAX3 genes were not common in a series of Iranian patients with familial strabismus. Moreover, by performing WES, we revealed that two variants of uncertain significance as possible causative variants for strabismus are not related to this disease in our population.

目的:在一系列伊朗斜视家族中寻找致病基因突变。此外,我们还系统地回顾了所有已发表的有关遗传变异在原发性和非综合征合并斜视中的作用的文章:方法:本研究选取了四个患有多例原发性和非综合征合并斜视的家庭。分别对阿贝尔森辅助整合位点 1(AHI1)、球蛋白(NEB)和配对盒 3(PAX3)基因的 23、11 和 3 号外显子进行了聚合酶链反应和 Sanger 测序。一名近亲结婚的后代接受了全外显子组测序(WES),以寻找可能的致病变异。为了进行系统综述,我们全面检索了 PubMed、Scopus 和 ISI 知识网,提取了 2021 年 4 月之前发布的相关出版物:我们研究了四个伊朗斜视家系,其不同世代的多个后代均患有斜视。在这 17 名参与者中,10 名家庭成员患有斜视,7 名家庭成员健康。桑格测序没有发现致病基因突变。因此,为了进一步研究,我们选择了一名受影响的后代进行WES研究。WES 研究显示,MYO5B 和 DHODH 基因中可能存在两种变异。这些基因变异在我们的人群中显示出较高的等位基因频率,被认为是我们这一系列伊朗家庭中的多态性:结论:我们证实,在一系列伊朗家族性斜视患者中,AHI1、NEB 和 PAX3 基因突变并不常见。此外,通过 WES,我们还发现两个意义不确定的变异可能是斜视的致病变异,但在我们的人群中,这两个变异与斜视无关。
{"title":"Role of Abelson Helper Integration Site 1, Nebulin, and Paired Box 3 Genes in the Development of Nonsyndromic Strabismus in a Series of Iranian Families: Sequence Analysis and Systematic Review of the Genetics of Nonsyndromic Strabismus.","authors":"Maliheh Rahpeyma, Aliakbar Sabermoghaddam, Mohammad Yaser Kiarudi, Amirsaeed Sabeti Aghabozorgi, Alireza Pasdar","doi":"10.4103/joco.joco_53_22","DOIUrl":"https://doi.org/10.4103/joco.joco_53_22","url":null,"abstract":"<p><strong>Purpose: </strong>To look for causative genetic mutations in a series of Iranian families with strabismus. In addition, we systematically reviewed all the published articles regarding the role of genetic variations in primary and nonsyndromic comitant strabismus.</p><p><strong>Methods: </strong>Four families with a history of multiple cases of primary and nonsyndromic comitant strabismus were enrolled in this study. Polymerase chain reaction and Sanger sequencing of exons 23, 11, and 3 of the Abelson helper integration site 1 (<i>AHI1</i>), nebulin (<i>NEB</i>), and paired box 3 (<i>PAX3</i>) genes were performed, respectively. One offspring of a consanguineous marriage underwent whole-exome sequencing (WES) to look for possible causative variants. To conduct a systematic review, we thoroughly searched PubMed, Scopus, and ISI Web of Knowledge extracting relevant publications, released by April 2021.</p><p><strong>Results: </strong>We examined four Iranian strabismus pedigrees with multiple affected offspring in different generations. Among these 17 participants, 10 family members had strabismus and 7 were healthy. Sanger sequencing did not reveal a causative mutation. Therefore, to further investigate, one affected offspring was chosen for WES. The WES study demonstrated two possible variants in <i>MYO5B</i> and <i>DHODH</i> genes. These genetic variants showed high allele frequency in our population and are thought to be polymorphisms in our series of Iranian families.</p><p><strong>Conclusions: </strong>We demonstrated that mutations in <i>AHI1</i>, <i>NEB</i>, and <i>PAX3</i> genes were not common in a series of Iranian patients with familial strabismus. Moreover, by performing WES, we revealed that two variants of uncertain significance as possible causative variants for strabismus are not related to this disease in our population.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feed the Eye to Heal the Eye. 养眼治眼
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_94_23
Giuseppe Merra, Marcello Covino, Andrea Piccioni, Marcello Candelli, Veronica Ojetti, Antonio Gasbarrini, Francesco Franceschi
{"title":"Feed the Eye to Heal the Eye.","authors":"Giuseppe Merra, Marcello Covino, Andrea Piccioni, Marcello Candelli, Veronica Ojetti, Antonio Gasbarrini, Francesco Franceschi","doi":"10.4103/joco.joco_94_23","DOIUrl":"https://doi.org/10.4103/joco.joco_94_23","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Oral Dextrose versus Acetaminophen versus Placebo on Pain Relief during Retinopathy of Prematurity Eye Examinations: A Randomized, Double-Blind Controlled Clinical Trial. 在早产儿视网膜病变眼部检查过程中,口服葡萄糖与对乙酰氨基酚和安慰剂的止痛效果:随机、双盲对照临床试验。
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_5_23
Hamed Riyahi Madvar, Mahla Shadravan, Hamid Mousavi, Amir Khosrou Ghasemi Nejad, Anis Shamsi, Siva Sr Iyer, Ramak Roohipourmoallai

Purpose: To assess the effect of oral dextrose versus acetaminophen versus placebo in pain relief in retinopathy of prematurity (ROP) examination.

Methods: In this prospective randomized, double-blind controlled clinical trial study performed in the ophthalmology clinic of Shafa Hospital (referral hospital for eye disease), Kerman, Iran, 105 premature neonates with birth weight ≤2000 g and gestational age between 28 and 34 weeks were studied. Pain score measurement with Premature Infant Pain Profile-Revised (PIPP-R) during ROP examination in three intervention groups, acetaminophen group (15 mg/kg oral acetaminophen), dextrose group (one cc of oral dextrose 50%), and placebo group (one cc of distilled water), was done.

Results: Out of 105 infants, 33 infants received acetaminophen drops, 35 infants received dextrose drops, and 37 infants received placebo. The mean pain score of the group receiving acetaminophen was 11.39, dextrose 12.17, and placebo 11.54. The acetaminophen group had a lower average PIPP-R score. This difference was not significant between the three groups (P = 0.38).

Conclusions: Acetaminophen and dextrose in comparison with distilled water did not show a significant difference in reducing neonatal pain during ROP examinations. However, the PIPP-R score in the acetaminophen group was lower compared to the other groups.

目的:评估在早产儿视网膜病变(ROP)检查中口服葡萄糖与对乙酰氨基酚和安慰剂的止痛效果:这项前瞻性随机、双盲对照临床试验研究在伊朗克尔曼沙法医院(眼病转诊医院)眼科诊所进行,研究对象为 105 名出生体重≤2000 克、胎龄在 28 至 34 周之间的早产新生儿。采用早产儿疼痛档案-修订版(PIPP-R)对三个干预组(对乙酰氨基酚组(15 毫克/千克口服对乙酰氨基酚)、葡萄糖组(1 毫升 50%葡萄糖口服液)和安慰剂组(1 毫升蒸馏水)进行了早产儿视网膜病变检查期间的疼痛评分测量:在 105 名婴儿中,33 名接受对乙酰氨基酚滴剂治疗,35 名接受葡萄糖滴剂治疗,37 名接受安慰剂治疗。对乙酰氨基酚组的平均疼痛评分为 11.39 分,葡萄糖组为 12.17 分,安慰剂组为 11.54 分。对乙酰氨基酚组的 PIPP-R 平均得分较低。三组之间的差异并不明显(P = 0.38):对乙酰氨基酚和葡萄糖与蒸馏水相比,在减轻 ROP 检查期间新生儿疼痛方面并无显著差异。然而,对乙酰氨基酚组的 PIPP-R 评分低于其他组。
{"title":"Efficacy of Oral Dextrose versus Acetaminophen versus Placebo on Pain Relief during Retinopathy of Prematurity Eye Examinations: A Randomized, Double-Blind Controlled Clinical Trial.","authors":"Hamed Riyahi Madvar, Mahla Shadravan, Hamid Mousavi, Amir Khosrou Ghasemi Nejad, Anis Shamsi, Siva Sr Iyer, Ramak Roohipourmoallai","doi":"10.4103/joco.joco_5_23","DOIUrl":"https://doi.org/10.4103/joco.joco_5_23","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the effect of oral dextrose versus acetaminophen versus placebo in pain relief in retinopathy of prematurity (ROP) examination.</p><p><strong>Methods: </strong>In this prospective randomized, double-blind controlled clinical trial study performed in the ophthalmology clinic of Shafa Hospital (referral hospital for eye disease), Kerman, Iran, 105 premature neonates with birth weight ≤2000 g and gestational age between 28 and 34 weeks were studied. Pain score measurement with Premature Infant Pain Profile-Revised (PIPP-R) during ROP examination in three intervention groups, acetaminophen group (15 mg/kg oral acetaminophen), dextrose group (one cc of oral dextrose 50%), and placebo group (one cc of distilled water), was done.</p><p><strong>Results: </strong>Out of 105 infants, 33 infants received acetaminophen drops, 35 infants received dextrose drops, and 37 infants received placebo. The mean pain score of the group receiving acetaminophen was 11.39, dextrose 12.17, and placebo 11.54. The acetaminophen group had a lower average PIPP-R score. This difference was not significant between the three groups (<i>P</i> = 0.38).</p><p><strong>Conclusions: </strong>Acetaminophen and dextrose in comparison with distilled water did not show a significant difference in reducing neonatal pain during ROP examinations. However, the PIPP-R score in the acetaminophen group was lower compared to the other groups.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Corneal Biomechanical Properties in Different Keratotopographic Patterns of Keratoconus. 不同角膜形态的角膜生物力学特性分析
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_83_23
Elena Gennadievna Solodkova, Boris Eduardovich Malyugin, Igor Nikolayevich Zakharov, Van Hoang Le, Sergey Viktorovich Balalin, Evgeniy Valeryevich Lobanov, Alexandr Sergeevich Balalin

Purpose: To analyze the frequency of main keratotopographic patterns at the 1st, 2nd, and 3rd stages of keratoconus and investigate corneal biomechanical properties across different patterns.

Methods: The study comprised two stages. The first stage was computational-experimental, where we utilized COMSOL Multiphysics® software (COMSOL AB, Stockholm, Sweden) to mathematically model corneal mechanical behavior under intraocular pressure and pulsed air jet action in both normal and keratoconic conditions. The second stage was the clinical phase, during which we retrospectively analyzed the examination results of both healthy subjects and patients with keratoconus. In total, the study included 256 eyes (256 subjects). Among them, 174 eyes (174 healthy individuals) had normal corneas with different refractions, and 82 eyes (82 individuals) had stages 1, 2, and 3 of keratoconus based on Amsler-Krumeich classification. The keratotopographic characteristics of the participants were assessed using Sirius (Schwind, Germany) and Pentacam AXL (OCULUS Optikgeräte GmbH, Germany) keratotomographs, while the corneal biomechanical properties were studied using noncontact tonometry with the Corvis ST device (OCULUS Optikgeräte GmbH, Germany). The study focused on evaluating corneal stiffness index values in the central optical zone under various keratotopographic patterns. In addition, it compared the elastic coefficient values c1, c2, and c3 for the model of hyperelastic behavior of corneal material outside the keratoconus zone. Furthermore, the study examined the values of reduced stiffness zone characteristics, including the stiffness reduction factor ψmax, effective radius Rk, and the ratio of maximum and minimum strain intensity in keratoconus of different stages.

Results: The mean age of the patients in the study was 30.16 ± 8.31 years, with 166 men and 90 women participating. The study revealed typical keratotopographic patterns in the examined keratoconus stages, as well as their occurrence frequency. In the 1st stage of keratoconus, the pattern of asymmetric astigmatism was noted more frequently (in 75% of cases). In the 2nd stage, the pattern with an ectasia zone in the lower cornea was observed in 80% of cases, and in the 3rd stage, a centrally located keratotopographic ectasia pattern was found in 42% of cases. Comparative analysis showed that the greatest decrease in stiffness parameter (SpA1) and stress-strain index occurred in the central pattern (by 64% and 46%, respectively), while the least decrease was observed in local corneal radius reduction in the lower cornea (by 42% and 33%, respectively).

Conclusions: The decrease in strength properties in keratoconus occurs in a local area, the size and degree of which a

目的:分析角膜炎第一、第二和第三阶段主要角膜形态的频率,并研究不同形态下的角膜生物力学特性:研究分为两个阶段。第一阶段是计算-实验阶段,我们利用 COMSOL Multiphysics® 软件(COMSOL AB,瑞典斯德哥尔摩)对正常和角膜炎患者在眼内压和脉冲气流作用下的角膜机械行为进行数学建模。第二阶段是临床阶段,我们对健康受试者和角膜炎患者的检查结果进行了回顾性分析。研究共包括 256 只眼睛(256 名受试者)。其中,174 只眼睛(174 名健康人)的角膜正常,屈光度各不相同,82 只眼睛(82 名健康人)的角膜按照 Amsler-Krumeich 分法分为 1 期、2 期和 3 期。研究人员使用 Sirius(德国 Schwind 公司)和 Pentacam AXL(德国 OCULUS Optikgeräte GmbH 公司)角膜曲率计对参试者的角膜地形图特征进行了评估,并使用 Corvis ST 设备(德国 OCULUS Optikgeräte GmbH 公司)的非接触式眼压计对角膜生物力学特性进行了研究。研究重点是评估各种角膜形态下中央光学区的角膜硬度指数值。此外,它还比较了角膜区外角膜材料超弹性行为模型的弹性系数值 c1、c2 和 c3。此外,研究还考察了不同阶段角膜病的硬度降低区特征值,包括硬度降低系数ψmax、有效半径Rk以及最大和最小应变强度之比:参与研究的患者平均年龄为(30.16 ± 8.31)岁,其中男性 166 人,女性 90 人。研究揭示了角膜病各期的典型角膜地形图模式及其发生频率。在角膜病的第一阶段,不对称散光的模式更为常见(占 75%)。在第二阶段,80%的病例观察到下角膜异位区的模式,而在第三阶段,42%的病例发现了位于中央的角膜异位模式。对比分析表明,中央模式的硬度参数(SpA1)和应力应变指数下降幅度最大(分别为64%和46%),而下角膜局部角膜半径缩小的下降幅度最小(分别为42%和33%):结论:角膜炎患者角膜强度特性的下降发生在局部区域,其大小和程度由疾病阶段决定。所显示的生物力学参数是一致的,与角膜形态和局部角膜形态无关,但与使用 Corvis ST 角膜气压计的诊断规范有关,该气压计可评估角膜顶部区域的角膜特性。
{"title":"Analysis of Corneal Biomechanical Properties in Different Keratotopographic Patterns of Keratoconus.","authors":"Elena Gennadievna Solodkova, Boris Eduardovich Malyugin, Igor Nikolayevich Zakharov, Van Hoang Le, Sergey Viktorovich Balalin, Evgeniy Valeryevich Lobanov, Alexandr Sergeevich Balalin","doi":"10.4103/joco.joco_83_23","DOIUrl":"https://doi.org/10.4103/joco.joco_83_23","url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the frequency of main keratotopographic patterns at the 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> stages of keratoconus and investigate corneal biomechanical properties across different patterns.</p><p><strong>Methods: </strong>The study comprised two stages. The first stage was computational-experimental, where we utilized COMSOL Multiphysics® software (COMSOL AB, Stockholm, Sweden) to mathematically model corneal mechanical behavior under intraocular pressure and pulsed air jet action in both normal and keratoconic conditions. The second stage was the clinical phase, during which we retrospectively analyzed the examination results of both healthy subjects and patients with keratoconus. In total, the study included 256 eyes (256 subjects). Among them, 174 eyes (174 healthy individuals) had normal corneas with different refractions, and 82 eyes (82 individuals) had stages 1, 2, and 3 of keratoconus based on Amsler-Krumeich classification. The keratotopographic characteristics of the participants were assessed using Sirius (Schwind, Germany) and Pentacam AXL (OCULUS Optikgeräte GmbH, Germany) keratotomographs, while the corneal biomechanical properties were studied using noncontact tonometry with the Corvis ST device (OCULUS Optikgeräte GmbH, Germany). The study focused on evaluating corneal stiffness index values in the central optical zone under various keratotopographic patterns. In addition, it compared the elastic coefficient values <i>c</i><sub>1</sub>, <i>c</i><sub>2</sub>, and <i>c</i><sub>3</sub> for the model of hyperelastic behavior of corneal material outside the keratoconus zone. Furthermore, the study examined the values of reduced stiffness zone characteristics, including the stiffness reduction factor ψ<sub>max</sub>, effective radius <i>R</i><sub>k</sub>, and the ratio of maximum and minimum strain intensity in keratoconus of different stages.</p><p><strong>Results: </strong>The mean age of the patients in the study was 30.16 ± 8.31 years, with 166 men and 90 women participating. The study revealed typical keratotopographic patterns in the examined keratoconus stages, as well as their occurrence frequency. In the 1<sup>st</sup> stage of keratoconus, the pattern of asymmetric astigmatism was noted more frequently (in 75% of cases). In the 2<sup>nd</sup> stage, the pattern with an ectasia zone in the lower cornea was observed in 80% of cases, and in the 3<sup>rd</sup> stage, a centrally located keratotopographic ectasia pattern was found in 42% of cases. Comparative analysis showed that the greatest decrease in stiffness parameter (SpA1) and stress-strain index occurred in the central pattern (by 64% and 46%, respectively), while the least decrease was observed in local corneal radius reduction in the lower cornea (by 42% and 33%, respectively).</p><p><strong>Conclusions: </strong>The decrease in strength properties in keratoconus occurs in a local area, the size and degree of which a","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Early Posttrabeculectomy Bleb Leakage on Surgical Outcome: A Prospective Cohort Study. 小梁切除术后早期出血对手术结果的影响:前瞻性队列研究
IF 1.5 Q2 Medicine Pub Date : 2024-03-29 eCollection Date: 2023-07-01 DOI: 10.4103/joco.joco_132_23
Maryam Yadgari, Maryam Oraee Yazdani, Pantea Karbasi, Mahya Naseripour, Ahmad Shojaei

Purpose: To evaluate the effect of early posttrabeculectomy bleb leakage on trabeculectomy surgery outcomes and success rate.

Methods: The present prospective cohort study was conducted on 203 eyes of 203 patients who underwent trabeculectomy at Torfeh and Imam Hossein Medical Centers, Tehran, Iran, between 2016 and 2021. Patients were divided into two groups: those with early bleb leakage (within the 1st month of surgery) and those without bleb leakage. The success rate of surgery was compared 12, 18, and 24 months after surgery in the two groups. The average intraocular pressure (IOP) and the need for medications in patients 1, 3, 6, 9, 12, 18, and 24 months after the trabeculectomy were also compared.

Results: Bleb leakage was detected in 33 eyes during the 1st month after a trabeculectomy (16.3%). The mean decrease in IOP in the group with leakage was significantly lower than in patients without leakage at 1, 6, 9, 12, 18, and 24 months after surgery (P < 0.05). The need for antiglaucoma medication was significantly higher among patients with bleb leakage at 3 months (P = 0.04) and 9 months (P = 0.047) after surgery (P < 0.05). The success rate at 12, 18, and 24 months after surgery was significantly lower in the group with leakage than the group without.

Conclusions: The results of our study suggest that early posttrabeculectomy bleb leakage negatively impacts surgery success. Furthermore, IOP reduction was lower in patients with early leakage.

目的:评估小梁切除术后早期眼泡渗漏对小梁切除术疗效和成功率的影响:本前瞻性队列研究针对 2016 年至 2021 年期间在伊朗德黑兰 Torfeh 和 Imam Hossein 医疗中心接受小梁切除术的 203 名患者的 203 只眼睛。患者分为两组:早期眼压渗漏(手术后一个月内)和无眼压渗漏。比较了两组患者术后 12、18 和 24 个月的手术成功率。此外,还比较了小梁切除术后 1、3、6、9、12、18 和 24 个月患者的平均眼压(IOP)和用药需求:在小梁切除术后的第一个月,有 33 只眼睛(16.3%)发现了眼泡渗漏。在术后 1、6、9、12、18 和 24 个月,有渗漏组患者的平均眼压降幅明显低于无渗漏组患者(P < 0.05)。术后 3 个月(P = 0.04)和 9 个月(P = 0.047),有眼泡渗漏的患者对抗青光眼药物的需求明显增加(P < 0.05)。术后12、18和24个月时,有渗漏组的成功率明显低于无渗漏组:我们的研究结果表明,小梁切除术后早期眼泡渗漏对手术成功率有负面影响。此外,早期渗漏患者的眼压降低率较低。
{"title":"The Effect of Early Posttrabeculectomy Bleb Leakage on Surgical Outcome: A Prospective Cohort Study.","authors":"Maryam Yadgari, Maryam Oraee Yazdani, Pantea Karbasi, Mahya Naseripour, Ahmad Shojaei","doi":"10.4103/joco.joco_132_23","DOIUrl":"https://doi.org/10.4103/joco.joco_132_23","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effect of early posttrabeculectomy bleb leakage on trabeculectomy surgery outcomes and success rate.</p><p><strong>Methods: </strong>The present prospective cohort study was conducted on 203 eyes of 203 patients who underwent trabeculectomy at Torfeh and Imam Hossein Medical Centers, Tehran, Iran, between 2016 and 2021. Patients were divided into two groups: those with early bleb leakage (within the 1<sup>st</sup> month of surgery) and those without bleb leakage. The success rate of surgery was compared 12, 18, and 24 months after surgery in the two groups. The average intraocular pressure (IOP) and the need for medications in patients 1, 3, 6, 9, 12, 18, and 24 months after the trabeculectomy were also compared.</p><p><strong>Results: </strong>Bleb leakage was detected in 33 eyes during the 1<sup>st</sup> month after a trabeculectomy (16.3%). The mean decrease in IOP in the group with leakage was significantly lower than in patients without leakage at 1, 6, 9, 12, 18, and 24 months after surgery (<i>P</i> < 0.05). The need for antiglaucoma medication was significantly higher among patients with bleb leakage at 3 months (<i>P</i> = 0.04) and 9 months (<i>P</i> = 0.047) after surgery (<i>P</i> < 0.05). The success rate at 12, 18, and 24 months after surgery was significantly lower in the group with leakage than the group without.</p><p><strong>Conclusions: </strong>The results of our study suggest that early posttrabeculectomy bleb leakage negatively impacts surgery success. Furthermore, IOP reduction was lower in patients with early leakage.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11047809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Treatment of Methanol-Induced Optic Neuropathy. 甲醇诱发视神经病变的急性治疗。
IF 1.5 Q2 Medicine Pub Date : 2023-12-21 eCollection Date: 2023-04-01 DOI: 10.4103/joco.joco_121_23
Najmeh Bahmanziari, Mohammad-Ali Kafashian, Seyed-Farzad Mohammadi, Alireza Lashay
{"title":"Acute Treatment of Methanol-Induced Optic Neuropathy.","authors":"Najmeh Bahmanziari, Mohammad-Ali Kafashian, Seyed-Farzad Mohammadi, Alireza Lashay","doi":"10.4103/joco.joco_121_23","DOIUrl":"10.4103/joco.joco_121_23","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139512368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Update on Anti-Vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity. 抗血管内皮生长因子治疗早产儿视网膜病变的最新进展。
IF 1.5 Q2 Medicine Pub Date : 2023-12-21 eCollection Date: 2023-04-01 DOI: 10.4103/joco.joco_38_23
M Hossein Nowroozzadeh, Elham Sadeghi, Hossein Shahriari-Garaee, Mohammad Reza Badie, Javad Banihashemi, Sunir J Garg

Purpose: To present updated information on the role of anti-vascular endothelial growth factor (anti-VEGF) therapy for treating retinopathy of prematurity (ROP).

Methods: We searched through PubMed and Scopus databases using the keywords of this article and gathered relevant published articles from the year 2005 to December 2022. The selected articles were classified and summarized, and reasonable conclusions were made accordingly.

Results: Considering the current evidence, anti-VEGF agents are superior to laser therapy for the initial treatment of type 1 ROP in zone 1 or posterior zone 2. However, there is a substantial risk of reactivation or persistent avascular retina after solo treatment with anti-VEGFs, and many cases may require laser therapy within the following weeks or months. Thus, vigilant follow-up examinations are mandatory.

Conclusions: The role of anti-VEGF agents in the treatment of ROP is indispensable. However, future studies are required to improve indications and dosage and determine long-term ocular and systemic safety.

目的:介绍抗血管内皮生长因子(anti-VEGF)疗法在治疗早产儿视网膜病变(ROP)中所起作用的最新信息:我们使用本文的关键词在 PubMed 和 Scopus 数据库中进行了检索,收集了 2005 年至 2022 年 12 月期间发表的相关文章。对所选文章进行分类和总结,并据此得出合理结论:考虑到目前的证据,抗血管内皮生长因子药物在初始治疗 1 区或后 2 区的 1 型 ROP 时优于激光治疗。然而,单用抗血管内皮生长因子治疗后,视网膜再激活或持续性无血管视网膜的风险很大,许多病例可能需要在接下来的几周或几个月内进行激光治疗。因此,必须进行警惕性随访检查:结论:抗血管内皮生长因子药物在治疗 ROP 中的作用不可或缺。结论:抗血管内皮生长因子药物在治疗视网膜病变中的作用是不可或缺的,但今后还需要进行研究,以改进适应症和剂量,并确定长期眼部和全身安全性。
{"title":"An Update on Anti-Vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity.","authors":"M Hossein Nowroozzadeh, Elham Sadeghi, Hossein Shahriari-Garaee, Mohammad Reza Badie, Javad Banihashemi, Sunir J Garg","doi":"10.4103/joco.joco_38_23","DOIUrl":"10.4103/joco.joco_38_23","url":null,"abstract":"<p><strong>Purpose: </strong>To present updated information on the role of anti-vascular endothelial growth factor (anti-VEGF) therapy for treating retinopathy of prematurity (ROP).</p><p><strong>Methods: </strong>We searched through PubMed and Scopus databases using the keywords of this article and gathered relevant published articles from the year 2005 to December 2022. The selected articles were classified and summarized, and reasonable conclusions were made accordingly.</p><p><strong>Results: </strong>Considering the current evidence, anti-VEGF agents are superior to laser therapy for the initial treatment of type 1 ROP in zone 1 or posterior zone 2. However, there is a substantial risk of reactivation or persistent avascular retina after solo treatment with anti-VEGFs, and many cases may require laser therapy within the following weeks or months. Thus, vigilant follow-up examinations are mandatory.</p><p><strong>Conclusions: </strong>The role of anti-VEGF agents in the treatment of ROP is indispensable. However, future studies are required to improve indications and dosage and determine long-term ocular and systemic safety.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139512411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Current Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1